Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesAre sedatives and hypnotics associated with increased suicide risk of suicide in the elderly?
BMC Geriatrics, 07/02/09
Carlsten A et al. - Antidepressants, antipsychotics, sedatives and hypnotics were associated with increased suicide risk in the crude analysis. After adjustment for affective and anxiety disorders neither antidepressants in general nor SSRIs showed an association with suicide. Antipsychotics had no association with suicide after adjustment for psychotic disorders. Sedative treatment was associated with an almost fourteen-fold increase of suicide risk in the crude analyses and remained an independent risk factor for suicide even after adjustment for any DSM-IV disorder. Having a current prescription for a hypnotic was associated with a four-fold increase in suicide risk in the adjusted model.
Related Articles
Weight Status, Psychological Health, Suicidal Thoughts, and Suicide Attempts in Dutch Adolescents: Results From the 2003 E-MOVO Project
Obesity, 11/03/09
Relevance Score: 93%
Associations between smoking and alcohol drinking and suicidal behavior in Korean adolescents: Korea Youth Behavioral Risk Factor Surveillance, 2006
Preventive Medicine, 10/20/09
Relevance Score: 92%
Suicide attempt by jumping: A study of gonadal axis hormones in male suicide attempters versus men who fell by accident
Psychiatry Research, 10/29/09
Relevance Score: 90%
Adolescent Suicide Risk Screening in the Emergency Department
Academic Emergency Medicine, 10/22/09
Relevance Score: 90%
A randomized controlled multicenter trial of post-suicide attempt case management for the prevention of further attempts in Japan (ACTION-J)
BMC Public Health, 10/02/09
Relevance Score: 90%
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Rates of Cognitive Change in Alzheimer Disease: Observations Across a Decade of Placebo-controlled Clinical Trials With Donepezil
Alzheimer Disease & Associated Disorders , 12/07/09
Neuroprotective and neurochemical properties of mint extracts
Phytotherapy Research, 12/07/09
Paliperidone palmitate maintenance treatment in delaying the time-to-relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled study
Schizophrenia Research, 12/06/09
Sponsor
Article Search
Sponsor